Frank Kung, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 1,161,717 shares at $21.25 ($24.7M) on 2013-09-16, disclosed to the SEC on 2013-09-17.
Open-market sale of $24.7M SGNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.25 | 539,017 | $11.5M | 46.4% |
| 2 | $21.25 | 622,700 | $13.2M | 53.6% |
| Total | $21.25 avg | 1,161,717 | $24.7M | 100% |
| Filing → |
| AMRS | SELL | 2021-04-15 | $140.0M | — | Filing → |
| AMRS | BUY | 2020-06-09 | $11.1M | — | Filing → |
| AMRS | BUY | 2019-05-01 | $8.7M | — | Filing → |